Literature DB >> 15136551

Generic isotretinoin: a new risk for unborn children.

Gideon Koren1, Marina Avner, Neil Shear.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136551      PMCID: PMC400722          DOI: 10.1503/cmaj.1040317

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Oral isotretinoin: prescribers beware.

Authors:  N H Shear
Journal:  CMAJ       Date:  1999-06-15       Impact factor: 8.262

2.  Substitution therapy for heroin addiction.

Authors:  James Bell; Alain Dru; Benedikt Fischer; Shabtay Levit; M Aamer Sarfraz
Journal:  Subst Use Misuse       Date:  2002 Jun-Aug       Impact factor: 2.164

3.  Roaccutane treatment guidelines: results of an international survey.

Authors:  W J Cunliffe; P C van de Kerkhof; R Caputo; S Cavicchini; A Cooper; O L Fyrand; H Gollnick; A M Layton; J J Leyden; J M Mascaró; J P Ortonne; A Shalita
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

Review 4.  Oral isotretinoin treatment policy. Do we all agree?

Authors:  J P Ortonne
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

5.  Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.

Authors:  Diane K Wysowski; Joslyn Swann; Amarilys Vega
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

6.  Adverse effects with isotretinoin.

Authors: 
Journal:  FDA Drug Bull       Date:  1983-11

Review 7.  Retinoid therapy of childhood cancer.

Authors:  C P Reynolds; R S Lemons
Journal:  Hematol Oncol Clin North Am       Date:  2001-10       Impact factor: 3.722

Review 8.  Isotretinoin made S.M.A.R.T. and simple.

Authors:  Eve J Lowenstein
Journal:  Cutis       Date:  2002-08

9.  Retinoic acid embryopathy.

Authors:  E J Lammer; D T Chen; R M Hoar; N D Agnish; P J Benke; J T Braun; C J Curry; P M Fernhoff; A W Grix; I T Lott
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

10.  Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas.

Authors:  Robert Wieder; Anna C Pavlick; Margarette Bryan; Meera Hameed; Soly Baredes; Lillian Pliner; Tracie Saunders; Reju Korah
Journal:  Am J Clin Oncol       Date:  2002-10       Impact factor: 2.339

  10 in total
  5 in total

1.  Patient-physician-regulator triad.

Authors:  Maria Valois; Robert Peterson; Léo Bouthillier
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

2.  Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

Authors:  Laurent Azoulay; Driss Oraichi; Anick Bérard
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

3.  Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.

Authors:  Nina Boucher; Louise Beaulac-Baillargeon
Journal:  Can Fam Physician       Date:  2006-03       Impact factor: 3.275

4.  Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.

Authors:  Elisabeth Autret-Leca; Carmen Kreft-Jais; Elisabeth Elefant; Hawaré Cissoko; François Darrouzain; Lamiae Grimaldi-Bensouda; Sarah Attia; Annie Pierre Jonville-Béra
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

5.  Papillon-lefevre syndrome: a combined approach from the dermatologist and dentist - a clinical presentation.

Authors:  Radhika Muppa; B Prameela; Mahesh Duddu; Arthi Dandempally
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.